Momenta Pharmaceuticals Inc. (MNTA)

13.65 -1.09 (-7.395%)

IEX Real-Time Price

October 19, 2018 EST.

Nasdaq Global Select : Healthcare

Prev Close 14.74

Price Open 14.67

Volume: 911,946

Avg Volume: 816,653

Market Cap: 1.07B

P/E Ratio -7.58

52 Wk Range 11.85-32.2



MNTA Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-09-28
74.07M
3.41M
7.64
4.60%

2018-09-14
74.07M
4.13M
11.26
5.58%

2018-08-31
74.07M
3.69M
9.72
4.99%

2018-08-15
74.05M
4.38M
8.63
5.92%




MNTA Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-08-09
Q2 2018
BTO
-0.46 (1)
-0.91
-0.45

2018-05-08
Q1 2018
BTO
0.00 (0)
-0.63
0.00

2018-05-02
Q1 2018
BTO
0.00 (0)
0.00
0.00

2018-05-01
Q1 2018
N/A
0.00 (0)
0.00
0.00

News

Momenta Pharma continues slide, down 8% (2018-10-16 12:22 SeekingAlpha)

Momenta Pharmaceuticals ( MNTA -7.5% ) slumps on double normal volume. Shares have dropped almost 50% since touching $26.48 on October 1. More news on: Momenta Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more …

 


Statistics

Shares Outstanding: 78.31M

Top 15 Institution Percent: N/A

Price To Sales: 13.99

Price To Book: 4.10

Revenue: 24.09M

Gross Profit: N/A

Cash: 418.79M

Debt: N/A

Return On Assets: -29.25

Return On Equity: -40.97

Profit Margin: N/A

Price History

Beta: 2.15

50-day Moving Avg: 24.39

200-day Moving Avg: 21.63

YTD Change: -4.88

5-day Change: -11.07

1-month Change: -49.91

3-month Change: -53.57

6-month Change: -33.41

1-year Change: -4.88

Revenue Per Share: 0.00

Revenue Per Employee: 86344.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Momenta Pharmaceuticals Inc.

Exchange: Nasdaq Global Select

Industry: Drug Manufacturers

Sector: Healthcare

Website: http://www.momentapharma.com

Momenta Pharmaceuticals Inc is a biotechnology company. It is engaged in developing generic versions of complex drugs, biosimilars and novel therapeutics for oncology and autoimmune disease.